Cargando…
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
The deregulation of lipid metabolism is a hallmark of tumor cells, and elevated lipogenesis has been reported in prostate cancer. Metformin, a drug commonly prescribed for type II diabetes, displays antitumor properties. Here, we show that metformin inhibits lipogenesis in several prostate cancer ce...
Autores principales: | Loubière, Camille, Goiran, Thomas, Laurent, Kathiane, Djabari, Zied, Tanti, Jean-François, Bost, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558177/ https://www.ncbi.nlm.nih.gov/pubmed/26002551 |
Ejemplares similares
-
Metformin targets the GTPase Rac1 to inhibit prostate cancer cell migration
por: Dirat, Béatrice, et al.
Publicado: (2014) -
Sirtuin 7: a new marker of aggressiveness in prostate cancer
por: Haider, Romain, et al.
Publicado: (2017) -
The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells
por: Loubiere, Camille, et al.
Publicado: (2017) -
Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019) -
In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis
por: Babaei Khorzoughi, Reyhaneh, et al.
Publicado: (2019)